Rockwell Medical (RMTI) Cash from Operations (QoQ) (2010 - 2026)
Rockwell Medical (RMTI) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Rockwell Medical | 29.87 Mn | 5.07 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,156.50% |
| Mar 31, 2026 | -108.89% |
| Dec 31, 2025 | 266.67% |
| Sep 30, 2025 | -171.54% |
| Jun 30, 2025 | 154.12% |
| Mar 31, 2025 | -503.12% |
| Dec 31, 2024 | -79.77% |
| Sep 30, 2024 | 196.46% |
| Jun 30, 2024 | 160.59% |
| Mar 31, 2024 | -5,434.88% |
| Dec 31, 2023 | 98.85% |
| Sep 30, 2023 | -115.69% |
| Jun 30, 2023 | 55.11% |
| Mar 31, 2023 | -3,360.71% |
| Dec 31, 2022 | 89.84% |
| Sep 30, 2022 | 81.33% |
| Jun 30, 2022 | 39.82% |
| Mar 31, 2022 | -8.70% |
| Dec 31, 2021 | -27.58% |
| Sep 30, 2021 | -43.28% |